New cancer drug is called impressive
Thursday, October 23, 2008 - 12:14
in Health & Medicine
GENEVA, Switzerland, Oct. 23 (UPI) -- U.S. scientists say an early trial of a multi-kinase inhibitor has shown impressive tumor shrinkage in patients with a hard-to-treat form of thyroid cancer.